These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15231048)

  • 61. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
    Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC
    Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of new and validated HPTLC methods for the qualitative and quantitative analysis of hyperforin, hypericin and hyperoside contents in Hypericum species.
    Saçıcı E; Yesilada E
    Phytochem Anal; 2022 Apr; 33(3):355-364. PubMed ID: 34734668
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development and evaluation of methods for determination of naphthodianthrones and flavonoids in St. John's wort.
    Williams FB; Sander LC; Wise SA; Girard J
    J Chromatogr A; 2006 May; 1115(1-2):93-102. PubMed ID: 16554056
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
    Wang EJ; Barecki-Roach M; Johnson WW
    J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Do other Hypericum species have medical potential as St. John's wort (Hypericum perforatum)?
    Stojanović G; Ðorđević A; Šmelcerović A
    Curr Med Chem; 2013; 20(18):2273-95. PubMed ID: 23521674
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Subchronic treatment with St John's wort produces a positive shift in emotional processing in healthy volunteers.
    Warren MB; Cowen PJ; Harmer CJ
    J Psychopharmacol; 2019 Feb; 33(2):194-201. PubMed ID: 30484733
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hypericum perforatum--chemical profiling and quantitative results of St. John's Wort products by an improved high-performance liquid chromatography method.
    Ganzera M; Zhao J; Khan IA
    J Pharm Sci; 2002 Mar; 91(3):623-30. PubMed ID: 11920747
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of pregnancies exposed to St. John's wort and their outcomes: A claims data analysis.
    Schäfer W; Wentzell N; Schink T; Haug U
    Reprod Toxicol; 2021 Jun; 102():90-97. PubMed ID: 33961968
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.).
    Fourneron JD; Naït-Si Y
    Phytochem Anal; 2006; 17(2):71-7. PubMed ID: 16634282
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
    Rückert U; Likussar W; Michelitsch A
    Phytochem Anal; 2007; 18(3):204-8. PubMed ID: 17500362
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neurochemical studies with St. John's wort in vitro.
    Simmen U; Higelin J; Berger-Büter K; Schaffner W; Lundstrom K
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S137-42. PubMed ID: 11518063
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.
    Borrelli F; Izzo AA
    AAPS J; 2009 Dec; 11(4):710-27. PubMed ID: 19859815
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
    Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
    J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cytological and biochemical effects of St. John's Wort supplement (a complex mixture of St. John's Wort, Rosemary and Spirulina) on somatic and germ cells of Swiss Albino mice.
    Aleisa AM
    Int J Environ Res Public Health; 2008 Dec; 5(5):408-17. PubMed ID: 19151436
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of vesicular uptake of monoamines by hyperforin.
    Roz N; Mazur Y; Hirshfeld A; Rehavi M
    Life Sci; 2002 Sep; 71(19):2227-37. PubMed ID: 12215370
    [TBL] [Abstract][Full Text] [Related]  

  • 77. St. John's Wort Herbal Teas - Biological Potential and Chemometric Approach to Quality Control.
    Kladar N; Anačkov G; Srđenović B; Gavarić N; Hitl M; Salaj N; Jeremić K; Babović S; Božin B
    Plant Foods Hum Nutr; 2020 Sep; 75(3):390-395. PubMed ID: 32447616
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Usefulness of studies on the molecular mechanism of action of herbals/botanicals: The case of St. John's wort.
    Choudhuri S; Valerio LG
    J Biochem Mol Toxicol; 2005; 19(1):1-11. PubMed ID: 15736155
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Measurement of hyperforin a constituent of St. John's wort in plasma by high-performance liquid chromatography.
    Chi JD; Franklin M
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):285-8. PubMed ID: 10670742
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
    Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
    JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.